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Abstract
Background: Infection by the liver fluke, Opisthorchis viverrini, remains an important public health problem in
Thailand and has resulted in the highest prevalence of infection and incidence of subsequent cholangiocarcinoma
(CCA) in the world. Praziquantel (PZQ) is the antihelminthic drug of choice for treatment. Previous studies in
hamsters showed that repeated infection and PZQ treatment could increase the risk of CCA. However, the few
available epidemiology studies in humans have shown unclear evidence of an increased risk of CCA with frequency
of PZQ intake. The present study investigated the relationship between the number of repeated PZQ treatments
and CCA.
Methods: A hospital-based matched case–control study was conducted. All cases and controls were inpatients of a
tertiary hospital in Northeast Thailand. During 2012–2014 a total of 210 incident cases of pathologically diagnosed
CCA and 840 control subjects were selected from a hospital inpatient database (four controls per case). The four
recruited controls were individually matched with CCA cases by gender, age and date of admission. Data were
collected in face-to-face interviews using a standardised pre-tested questionnaire. Multivariable conditional logistic
regression was used in the analysis of the data.
Results: The frequencies of PZQ usage among the 210 cases and 840 controls were 48.6 vs. 66.0 for never, 32.9 vs.
24.4 for once, 8.6 vs. 4.9 for twice, and 10.0 % vs. 4.8 % for more than twice, respectively. There was a statistically
significant dose–response relationship (p < 0.001). Compared with subjects who never used PZQ, those who used
the medication once, twice, and more than twice were 1.49, 1.82, and 2.30 times more likely to develop CCA
(95 % confidence intervals: 1.02 - 2.20, 0.92 - 3.60, and 1.20 - 4.40). These odds ratios (adjusted ORs) had already
been adjusted for the effects of eating raw fish, a family history of cancer, and highest educational attainment.
Additional PZQ usage increased the odds of developing CCA by 23.0 % (adjusted OR = 1.23; 95 % CI: 1.07 - 1.43).
Conclusions: The findings show that repeated PZQ treatments are associated with an increased risk of CCA.
Paradoxically, this contradicts the common belief that repeated PZQ treatments decrease the risk of CCA. The study
also showed a strong association between the number of repeated PZQ treatments and the consumption of raw
freshwater fish. This suggests that repeated PZQ treatments may be a surrogate marker of habit of eating raw fish.
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Background
Opisthorchis viverrini (O. viverrini), known as the
Southeast Asian liver fluke, is a food-borne trematode
parasite found in tropical countries. In Thailand, liver
fluke infection caused by O. viverrini is still an import-
ant public health problem. The tradition of eating cul-
turally popular dishes involving the use of raw, partially
cooked or underfermented cyprinid fish, which may
contain the infective stage (metacercariae) of O. viver-
rini, continues to occur in the northeast region. This
practice has resulted in the highest prevalence of O.
viverrini infection and incidence of subsequent cholan-
giocarcinoma (CCA) in the world [1–3]. CCA is a bile
duct cancer, which originates in biliary epithelial cells,
and occurs in the intrahepatic and extrahepatic regions
of the bile duct, but it does not include malignancies in
the gallbladder or the ampulla of Vater [4–6].
The infection is endemic in the Lower Mekong region
of SE Asia, which includes Thailand and the Lao People’s
Democratic Republic (Laos PDR). In Thailand, as many as
8 million people are infected with the liver fluke O. viver-
rini, and 2 million in Laos PDR. Approximate 80.0 % of all
Thai cases occur in the north and northeast regions of
Thailand [7, 8]. Reliable data are only rarely available for
the prevalence of O. viverrini infection and incidence of
CCA in other countries of the Lower Mekong region such
as Cambodia and Vietnam. In Cambodia, the apparent
infection rate of Opisthorchis spp. is 4.0 % [9], while in
Vietnam the infection by O. viverrini has been reported to
be endemic in its southern region [10]. The popular
northeast Thai habit of eating raw, undercooked or im-
properly fermented cyprinid freshwater fish puts people at
risk of O. viverrini infection [2, 3] when the foods con-
sumed are contaminated by the viable metacercariae of
the parasite [8].
The prevalence of liver fluke infection caused by O.
viverrini in Thailand is distributed predominantly in the
north and northeast regions where the rates are 19.3 and
15.7 %, respectively [7, 11]. However, there has appar-
ently been a wide geographical regional and local vari-
ation. In the 19 northern provinces, infection rates have
been reported to vary between (4.6 – 60.8 %) [12], and
similar large variations in rates by intestinal parasites
(mainly O. viverrini) can also occur within a province
[13]. In Khon Kaen Province, prevalence rates of O.
viverrini between 2.0 and 71 % have been recorded in its
various provincial districts [14].
For Thai people, the age-standardized rate (ASR) of
liver cancer and bile duct cancer is between 67.6 and
94.8 per 100 000 people in males and between 27.3 and
39.4 per 100 000 in females. The most common histo-
logical type is CCA, which comprises between 82.0 and
89.0 % of all detected primary liver cancers [15–20]. In
Northeast Thailand, it is estimated that 5000 new cases
of CCA are diagnosed every year [21]; this means that
each year about 5000 deaths are added to the overall
burden of chronic liver and bile duct disease [8].
In Thailand, there have been few previous studies
investigating risk factors for CCA, but almost all have
emphasized the role of O.viverrini infection in the subse-
quent development of CCA. For instance, the areas with a
high incidence of CCA have also been shown to have a high
prevalence of O. viverrini infection, and both epidemio-
logical studies of humans and laboratory experiments in
hamsters have shown that O. viverrini infections are associ-
ated with CCA [22–25]. Other important potential risk
factors for CCA have included antibody titre for O.viverrini,
the number of praziquantel treatments, the consumption of
alcohol, and genetic polymorphism. All of these have been
shown to have a statistically significant association with
CCA [26–28].
Praziquantel (PZQ) provides effective chemotherapy.
It has been and remains the drug of choice to treat O.
viverrini infection [29, 30]. However, rapid re-infection
after successful PZQ treatment has been found to occur,
and a high rate of almost 90 % re-infection within one year
has been recorded in Khon Kaen Province [12, 31, 32].
People enjoy eating raw, undercooked or inadequately
fermented freshwater fish and are aware that PZQ is an
effective treatment. Hence, after becoming infected and
treated, they return to eating cultural dishes of unsafely
prepared fish, become re-infected, and again obtain PZQ
for treatment, thus perpetuating the cycle [1, 12, 33].
This seems to have contributed to the continued persist-
ence of CCA in the region [34, 35].
Previous studies in hamsters infected with O.viverrini
have shown that repeated infection and PZQ treatment
may increase the risk of CCA. More frequent O.viverrini
infections can induce the expression of inducible nitric
oxide syntheses (iNOS), not only in inflammatory cells,
but also in the epithelium of the bile ducts. This can
subsequently cause nitrosative and oxidative damage to
nucleic acids, and this damage may play a part in the
initiation and/or promotion of steps in the development
of CCA [36–38]. Extensive use of repeated doses of PZQ
may be a specific factor which needs to be evaluated in
relation to the use of this drug and the development of
neoplasms in humans [39].
However, the few available epidemiology studies in
humans have failed to provide clear evidence of an in-
creased risk of CCA with frequency of PZQ intake. The
current study was designed to measure the independent
association between CCA and various potential risk
factors such as the use of PZQ [26]. One of the prob-
lems with previous research into this issue has been the
inadequacy of case-definition: for example, in the most
relevant previous study histological diagnosis was pro-
vided for only 28.0 % of CCA cases. This deficiency
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could lead to misclassification and could distort the
odds ratios, resulting in an underestimate of the real
problem. The main purpose of the present study was to
investigate the relationship between the number of re-
peated PZQ treatments and CCA.
Methods
Study design
We conducted a hospital-based matched case–control
study of patients admitted to Srinagarind Hospital in the
city of Khon Kaen, Northeast Thailand. This facility is a
regional tertiary referral centre and the main teaching hos-
pital for the Faculty of Medicine at Khon Kaen University.
A total of 210 cases were all incident cases with patho-
logically confirmed CCA. The controls were 840 sub-
jects, who were selected from the hospital inpatient
database (four controls per case). The four controls were
individually matched with each CCA case by gender, age
(within five years) and date of admission (within three
months). Age and gender were chosen as matching vari-
ables because previous studies have found that both
factors were associated with CCA and repeated PZQ
treatments [26, 40].
Data were collected from the recruited inpatients by a
face-to-face interview with a trained interviewer using a
standardised pre-tested questionnaire (the English lan-
guage version is attached as an Additional file 1). The
questionnaire was developed by researchers and vali-
dated by specialists in the field of CCA and a pilot-test
conducted on 10 cases and controls. Items in the ques-
tionnaire were designed to elicit information about
potential risk factors and included questions about
demographic variables, the ingestion of raw, partially
cooked or possibly underfermented fish, a family history
of cancer, use of toxic chemicals, alcohol consumption,
smoking behavior, and a history of eating local nitrite-
containing foods.
Eligibility criteria and operational definitions
The eligibility criteria for both cases and controls were:
1. The subject had provided signed informed consent
to participate in the study.
2. The subject was able to speak and understand Thai,
could provide reliable information, and was both
well enough and sufficiently intact cognitively to
respond to the interview questions. This criterion
was determined by the trained interviewer.
Cases
The following additional eligibility criteria were used to
define an individual as a CCA case:
1. The subject was an inpatient, who was an incident
case of CCA and had been admitted and diagnosed
between September 1, 2012, and July 31, 2014, at
Srinagarind Hospital.
2. The CCA was the primary diagnosis and was
histologically confirmed by pathologists from the
Department of Pathology in the Faculty of Medicine,
Khon Kaen University.
Controls
The following additional eligibility criteria were used to
define an individual as a control:
1. The subject was an inpatient, who was admitted to
Srinagarind Hospital between September 1, 2012,
and July 31, 2014.
2. The subject was selected from the Srinagarind
Hospital inpatient database.
3. The subject had no history of hepatic disease, liver
cancer, CCA, or any other malignancy. This was
determined from medical records by a researcher
assistant. The hospital departments from which the
controls were recruited were the Departments of
Otolaryngology, Ophthalmology, Rehabilitation, and
Orthopedics.
The process for the recruitment and enrolment of
cases and controls is summarised in Fig. 1.
Factor of interest
The factor of interest was the number of repeated treat-
ments with PZQ. The frequency of PZQ treatment was
categorised into four groups: never used, used once, used
twice, and used more than twice. The trained interviewer
showed a sample of PZQ to each participant when asking
about PZQ treatment history.
Potential confounders
Confounding factors were variables which were
already known to be associated with CCA. These
were various demographic characteristics, use of
toxic chemicals, smoking behavior, alcohol consump-
tion, a history of eating local nitrite-containing
foods, the consumption of raw, partially cooked, or
possibly underfermented fish, and a family history of
cancer.
A history of use of toxic chemicals comprised the use
of (1) herbicides, (2) rodenticides, (3) insecticides, and
(4) fungicides.
Smokers (as opposed to ‘never smokers’) included
ex-smokers (smoked for at least once day in the past,
but quit the habit more than one year previously), oc-
casional smokers (those now smoking less than once
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per day), and current smokers (those smoking at least
once per day).
Drinkers of alcohol (as opposed to ‘never drinkers’)
included ex-drinkers (used alcohol at least once a
day in the past, but quit drinking more than a year
previously), occasional drinkers (those presently
using alcohol less than once a day), and current
drinkers (those using alcohol at least once a day).
A history of eating local nitrite-containing foods
comprised the eating of (1) salted freshwater fish
and salted meat, (2) fermented fish products such as
Pla-chao and Pla-chom, (3) grilled or smoked meat,
and (4) sausages (including Chinese sausages).
Sample size calculation
The estimated required sample sizes for cases and con-
trols were 203 and 812, respectively. This was based on
a method of estimating sample sizes in pair-matched
case control studies [41], an adjustment for the variance
inflation factor [42], and the case–control ratio of 1:4
(see an Additional file 2 for details of sample size estima-
tion procedure).
Fig. 1 Patient enrollment, cases with CCA and controls
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Data processing
The data were entered into a computer using the Online
Medical Research Tools, OMERET [43]. Stata statistical
software [44] was used for data verification, and data-
entry errors were corrected. When questionnaires were
found to be incomplete, the participants were contacted
by the researcher to obtain the missing information.
Statistical analyses
Description of demographic characteristics of cases and
controls
The characteristics of the subjects were summarised using
descriptive statistics. Means and standard deviations, me-
dians and their ranges (minimum and maximum) were
used for continuous variables, and frequency counts and
percentages were used for categorical variables.
Crude analysis
A crude analysis was performed to determine the associ-
ations of the number of repeated PZQ treatments and
other factors with CCA without controlling for variable
confounding. Crude odds ratios (ORcrude) and their 95 %
confidence intervals (95 % CI) were computed by bivari-
ate conditional logistic regression.
Test for linear trend
A trend test was used to determine if there was a dose
response relationship between the numbers of PZQ treat-
ments and the risk of CCA. The test used was the Mantel-
Haenszel extension of the chi-square test [41].
Interaction effects
Possible interaction effects were identified in the bivari-
ate analysis by the use of Mantel-Haenszel chi-square
test of homogeneity [41].
Multivariable analysis
Multivariable conditional logistic regression [45, 46] was
used to compute adjusted odds ratios (ORadj.) and their
95 % confidence intervals (95 % CI) for investigating the
effect of the number of repeated PZQ treatments on
CCA, while controlling for the effects of confounding
variables. Candidate variables for the multivariable ana-
lysis were selected according to two criteria: firstly, vari-
ables in the crude analysis which were found to have a
p-value of less than 0.25, and secondly, variables shown
from a literature review to have an association with
CCA. The method of backward stepwise elimination
was used as the model fitting strategy. A likelihood ra-
tio test was performed to assess the goodness-of-fit of
the final model.
All analyses were performed using Stata version 10.0
[44]. All test statistics were two-sided, and a p-value of
less than 0.05 was considered statistically significant.
Ethical considerations
This project was approved by the Human Research and
Ethics Committee of Khon Kaen University (Reference
No. HE551032). All participants were informed about
the objective of the study before being invited to sign
the consent form.
Results
A total of 210 subjects were recruited as CCA cases and
840 were available for analysis as controls. None of the
otherwise eligible patients declined consent to partici-
pate. Table 1 summarises the outcome of the matching
procedure. For all three matching variables, the percent-
ages of cases and control are the same or similar.
Demographic characteristics: unmatched variables
Of the 210 subjects who were recruited as CCA cases, al-
most all (97.1 %) were born and resided in the northeast
(E-san) region, and 92.4 % spoke the local Thai (E-san)
dialect as their first language. A large proportion (80.5),
were married, and 99.5 % were Thai nationals. All re-
ported being Buddhists, 79.1 % had only primary school
education, 74.8 % were currently working in agriculture
(for example, as farmers or horticulturalists), and their
median personal monthly income was 3,000.00 baht
(range: 500.00 - 90000.00). For the 840 control subjects,
the vast majority (92.9) were born and resided in the
northeast (E-san), and 82.6 % spoke in the local Thai
(E-san) dialect as their first language. A large propor-
tion (79.5 %), were married, 99.6 % were Thai nationals,
99.6 % were Buddhists, 68.1 % attended only primary
schools, 58.7 % currently worked in agriculture, and
their median personal monthly income was 40000.00
baht (range: 400.00 - 600000.00).
Crude analysis
The results of this analysis are shown in Table 2. The
factors found to be significantly associated with CCA
were number of PZQ treatments, highest educational
attainment, rodenticide use, alcohol consumption, the
eating of raw or partially raw fish (such as Lab-Pla,
Koi-Pla), the eating of fermented fish products (such
as Pla-chao, Pla-chom), the eating of Chinese sausage/
other sausage, the eating of fermented fish (Pla-ra), and a
family history of cancer. Additional PZQ usage increased
the odds of developing CCA by 33.0 % (ORcrude = 1.33;
95 % CI: 1.16 - 1.51; p < 0.001). There was a statistically
significant dose response relationship (p < 0.001).
Herbicide, insecticide and fungicide use, smoking
behavior, and the consumption of salted freshwater fish/
salted meat, grilled/smoked meat were not significantly
associated with CCA.
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Association between CCA, chemical exposures and
nitrite-containing food: combining variables
We combined the four chemical variables (herbicide, ro-
denticide, insecticide, and fungicide use) into one variable,
‘yes’ or ‘no’, depending on whether the subject reported ever
having used one or more of the chemicals on at least one
occasion. Likewise, we also combined variables about the
consumption of local nitrite-containing foods (salted fresh-
water fish and salted meat, fermented fish products such as
Pla-chao and Pla-chom, grilled/smoked meat, and Chinese
sausage/other sausages) into one variable, ‘yes’ or ‘no’, de-
pending on whether the subject reported ever having con-
sumed one or more of the foods on at least one occasion.
The decision to combine these variables was made because
of concern that subjects may have been unable to make reliable
distinctions between the four different types of chemical expo-
sures and between the four kinds of nitrite-containing foods.
The outcome of combining these variables in the uni-
variate analysis is shown in Table 2.
Association between use of PZQ treatments and the
consumption of raw freshwater fish
There was a statistically significant association between
number of PZQ treatments and the consumption of raw
freshwater fish (p < 0.001) (Table 3).
Interaction term between number of repeated PZQ
treatments and chemical environment exposure
A highly significant interaction effect (p < 0.001) was found
between repeated PZQ treatments and the use of toxic
chemicals. The association between CCA and number of
repeat PZQ treatments was significantly higher in those
reporting use of a toxic chemical.
Multivariable analysis
Factors associated with CCA
Table 4 shows the outcome of the multivariable analysis.
The number of PZQ treatments was significantly associ-
ated with CCA. Using subjects who never used PZQ as
the reference group, the odds of developing CCA for those
who used PZQ once, twice, and more than twice were,
respectively, 1.49 (95 % CI: 1.02 - 2.20), 1.82 (95 CI: 0.92 -
3.60, and 2.30 (95 % CI: 1.20 - 4.40) times more likely to
develop CCA than those who had never used the medica-
tion. An additional PZQ use increased the odds of devel-
oping CCA by 23.0 % (ORadj. = 1.23; 95 % CI: 1.07 - 1.43).
Subjects who consumed raw freshwater fish had 2.73 times
more likely to develop CCA compared with subjects who
did not consume this food (ORadj. = 2.73; 95 % CI: 1.88 -
3.95). A family history of cancer was also a statistically
significant risk factor (ORadj. = 2.54; 95 % CI: 1.82 - 3.95).
Table 1 Outcome of case–control matching procedure
Variables Cases Controls
Number (n = 210) Percent (%) Number (n = 840) Percent (%)
Gender
Male 126 60.0 504 60.0
Female 84 40.0 336 40.0
Age at recruitment (years)
30 - 40 3 1.4 14 1.7
41 - 50 22 10.5 102 12.1
51 - 60 83 39.5 327 38.9
Older than 60 102 48.6 397 47.3
Mean (standard deviation) 60.7 (8.3) 60.3 (8.6)
Median (minimum: maximum) 60.5 (36.5: 83.2) 60.8 (32.7: 83.2)
Date of admission (Sep 2012-Jul 2014)
1st year: recruitment
Sep 2012 - Nov 2012 22 10.5 85 10.1
Dec 2012 - Feb 2013 12 5.7 60 7.1
Mar 2013 - May 2013 25 11.9 73 8.7
Jun 2013 - Aug 2013 28 13.3 107 12.7
2nd year: recruitment
Sep 2013 - Nov 2013 28 13.3 70 8.3
Dec 2013 - Feb 2014 54 25.7 199 23.7
Mar 2014 - May 2014 21 10.0 139 16.6
Jun 2014 - Jul 2014 20 9.5 107 12.7
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Table 2 Crude odds ratios for CCA associations with various risk factors
Characteristics Cases (n = 210) Controls (n = 840) Crude OR 95 % CI P-value
Number of PZQ treatments (times) - - 1.33 1.16 - 1.51 <0.001
Number of PZQ treatments (times) <0.001
0 48.5 65.9 1 -
1 32.9 24.4 1.93 1.35 - 2.77
2 8.6 4.9 2.72 1.45 - 5.07
More than 2 10.0 4.8 3.20 1.75 - 5.74
Test for linear trend (1df) <0.001
Highest educational attainment 0.003
Primary school 79.1 68.1 1 -
Secondary school 3.8 6.2 0.51 0.24 - 1.10
High school or Diploma 9.5 10.5 0.76 0.45 - 1.28
Bachelor’s degree 7.6 15.2 0.40 0.23 - 0.71
Herbicide use 0.375
No 79.5 82.0 1 -
Yes 20.5 18.0 1.20 0.80 - 1.80
Rodenticide use 0.001
No 70.5 81.1 1 -
Yes 29.5 18.9 1.81 1.28 - 2.57
Insecticide use 0.884
No 87.6 87.3 1 -
Yes 12.4 12.7 0.97 0.60 - 1.56
Fungicide use 0.421
No 96.7 97.6 1 -
Yes 3.3 2.4 1.45 0.58 - 3.61
Smoking behavior 0.045
Never smoked 45.2 50.1 1 -
Smoker 54.8 49.9 1.74 1.01 - 3.00
Alcohol use 0.030
Never used 33.8 40.0 1 -
Drinkers 66.2 60.0 1.60 1.05 - 2.45
Salted fresh water fish, salted meat 0.474
No 11.0 12.7 1 -
Yes 89.0 87.3 1.19 0.73 - 1.94
Raw, partially cooked raw fish
(e.g. Lap-Pla, Koi-Pla)
<0.001
No 38.6 61.7 1 -




No 23.3 35.1 1 -
Yes 76.7 64.9 1.87 1.30 - 2.71
Grilled/smoked meat 0.892
No 1.4 1.3 1 -
Yes 98.6 98.7 0.91 0.25 - 3.36
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Education beyond high school/diploma level was a signifi-
cant protective factor (ORadj. = 0.40; 95 % CI: 0.23 - 0.71).
Discussion
The primary aim of this study was to investigate the re-
lationship between the number of repeated PZQ treat-
ments and CCA. The findings showed that patients who
had repeated PZQ treatments were at a substantial risk
for developing CCA. This does not mean that there is a
direct association between repeated use of PZQ and
CCA risk: PZQ is usually only administered when some-
one is found or suspected to be infected by O. viverrini,
so that repeat treatments are therefore likely to be con-
founded with re-infection rates.
Other factors found to be highly significantly associated
with CCA were the consumption of raw fish, a history of
cancer in the family, and educational background.
In Thailand, there is considerable concern about the
high incidence of CCA, and previous studies have pro-
vided only very limited information about the number of
repeated PZQ treatments and other potential risk factors
for the disease. Consequently, while we can be highly
confident about the role of O. viverrini infection, no de-
finitive statements can be made at this time about vari-
ous other suspected risk factors.
Risk factors assessment
Number of repeated PZQ treatments
For this study, the number of repeated PZQ treatments
was significantly and positively associated with an
increased risk of CCA, and there was a statistically sig-
nificant dose response relationship. After its first use,
each additional PZQ treatment increased the odds of
developing CCA by 23.0 %. This is consistent with a pre-
vious study in Thailand [26] which reported statistically
significant adjusted odds ratios of 3.04 and 4.60 for those
who used PZQ once and more than once. In one study,
the odds of developing CCA was found to be 2.16 times
more likely to develop CCA in those who used PZQ
than in those who had not, but this result was not statis-
tically significant [27]. Similar non-significant findings
were reported in two other studies [40, 47].
CCA may be induced by the combination of O. viverrini
infection and exposure to carcinogens such as nitrosamine-
Table 2 Crude odds ratios for CCA associations with various risk factors (Continued)
Chinese sausage/other sausages
No 35.2 23.0 1 - <0.001
Yes 64.8 77.0 0.54 0.38 - 0.75
Fermented fish (Pla-ra) 0.041
No 1.4 4.6 1 -
Yes 98.6 95.4 3.5 1.06 - 11.5
History of cancer in family <0.001
No 50.0 72.1 1 -
Yes 50.0 27.9 2.56 1.87 - 3.51
Combining variables
Local nitrite-containing foods 0.156
No 57.6 62.9 1
Yes 42.4 37.1 1.25 0.92 - 1.71
Environmental chemical use <0.001
No 55.7 68.7 1
Yes 44.3 31.3 1.81 1.31 - 2.50







Crude OR Adjusted OR 95 % CI P-value
Number of used PZQ treatments (times) <0.001
0 54.1 68.8 1 1 -
1 29.0 23.9 1.87 1.87 1.30 - 2.70
2 8.0 3.8 3.19 2.99 1.48 - 6.03
Greater than 2 8.9 3.5 3.27 3.11 1.61 - 6.02
(After adjustment for alcohol consumption and highest educational attainment)
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rich foods [48, 49]. The proposed pathways linking CCA
initiation to the parasite are (1) mechanical damage, (2)
molecular products, (3) malfunction and hijacking of the
immune system (when combined, these mechanisms result
in several common elements which lead to DNA damage),
and (4) inhibition of the normal DNA damage response
which dramatically increases the likelihood of a malignant
transformation [3]. The results of the present study suggest
an association between the number of PZQ treatments and
the risk of CCA. While repeated PZQ treatments cannot be
directly related to CCA, they may be having an effect in
combination with O. viverrini infections, possibly by initiat-
ing or augmenting the mechanisms of opisthorchis-derived
CCA.
One epidemiological study revealed that subjects with
a history of using PZQ on 2–4 occasions were 4.6 times
more likely to develop CCA than who never used this
drug [48]. This finding might be explained by reference
to studies using an animal model. In an experiment with
hamsters subjected to a single infection or two or three
re-infections, oxidative and nitrosative DNA damage was
found occur to faster with successive infections [36]. In an-
other study the use of PZQ as a short-term term treatment
of infected hamsters was found to activate an O.viverrini
antigen burst which induced oxidative and nitrosative
stress [50]. To the best of our knowledge, a chronic inflam-
matory process is one predisposing factor for CCA.
Number of repeated PZQ treatments and eating raw fish
Importantly, our results also showed that the number of
repeated PZQ treatments was significantly associated
with the consumption of raw freshwater fish. People
who reported repeated PZQ treatments were more likely
to report this dietary practice. When people consume
raw freshwater fish, they often obtain PZQ as prophylactic
treatment in order to eliminate the possibility of conse-
quent O. viverrini infection. Paradoxically, many people
believe that PZQ has a protective effect against further in-
fection by O. viverrini and hence reduces the risk of CCA
[51]. PZQ treatment may therefore be a surrogate variable
for the behavior of consuming raw freshwater fish and by
extension, when not used prophylactically, for infestation
with the liver fluke O. viverrini.
In the primary prevention of CCA, considerable im-
portance should be attached to reducing the risk of O.
viverrini infection by attempts to eliminate the practice
of consuming raw freshwater fish or freshwater fish
products which are unsafely prepared due to undercook-
ing or underfermentation.
Eating raw fish and CCA risk
Previous studies have shown the eating of raw fish is
associated with an increased risk of CCA in Thailand. In
one Thai study the odds of developing CCA were 2.94
times more likely to develop CCA in those who ate
freshwater fish twice or more per month than in those
who had not consumed raw fresh water [27]. Another
previous study reported the odds of developing CCA
were 1.60, 2.50, and 10.20 times more likely in those
who consumed raw freshwater fish monthly, weekly, and
daily, respectively, compared with those did not eat raw
freshwater fish [13]. Similarly, a further study reported
Table 4 Adjusted odds ratios for CCA associations with various risk factors
Characteristics Cases (n = 210) Controls (n = 840) Crude OR Adjusted OR 95 % CI P-value
Number of used PZQ treatments (times) - - 1.33 1.23 1.07 - 1.43 0.005
Number of used PZQ treatments (times) 0.025
0 48.5 65.9 1 1 -
1 32.9 24.4 1.93 1.49 1.02 - 2.20
2 8.6 4.9 2.72 1.82 0.92 - 3.60
More than 2 10.0 4.8 3.17 2.30 1.20 - 4.40
Eating raw fish <0.001
No 38.6 61.7 1 1 -
Yes 61.4 38.3 3.10 2.73 1.88 - 3.95
History of cancer in family <0.001
No 50.0 72.1 1 1 -
Yes 50.0 27.9 2.56 2.54 1.82 - 3.55
Highest educational attainment 0.011
Primary school 79.1 68.1 1 1 -
Secondary school 3.8 6.2 0.51 0.56 0.25 - 1.25
High school/diploma 9.5 10.5 0.76 0.76 0.44 - 1.34
Bachelor’s degree 7.6 15.2 0.40 0.41 0.23 - 0.75
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that the odds of CCA were 3.08 and 3.40 times more
likely in those who ate raw freshwater fish for 1–4 times
per month or three times per week compared with those
did not eat raw freshwater fish [47]. All these results are
consistent with those obtained in the current study.
The problem of food safety has been shown to be asso-
ciated with an increased risk of CCA [7]. The traditional
habit of eating ground, raw or undercooked or underfer-
mented freshwater fish on a regular basis has repeatedly
exposed the local population to liver fluke infection since
childhood [52, 53].
National public health control programmes to prevent
liver fluke infection caused by O. viverrini rely on stool
examinations and the treatment of positive cases with
PZQ, health education, and the improvement of hygienic
defecation [54], but the success of these primary prevention
strategies has yet to be convincingly demonstrated [55].
History of cancer in family
A family history of cancer has previously been shown to
be significantly associated with an increased risk of CCA
in several previous studies in Thailand. In one study
[26], the odds of CCA were 2.10 times more likely to
develop CCA in people with a family of history of cancer
than in those who reported no family history. In another
study [47], patients with a family history of cancer com-
pared with those who did not were found to have 4.3
times the odds of developing CCA: this is higher than the
odds found in the present study. In a third study, a posi-
tive association was found between a family history of can-
cer and CCA, but it was not statistically significant [40].
Highest educational attainment
The finding of the present study that high education
to at least a bachelor’s degree level was protective fac-
tor for CCA has not previously been reported in a
Thai population. One previous case–control study in
Northeast Thailand found no association between
educational background and CCA, but the subjects
were assessed simply as educated or not educated and
literate or illiterate [27]. In another northeast Thai
case–control study there was similarly no relationship
between education and the risk of CCA, but subjects
were categorised only as illiterate, completing primary
school education and attaining secondary school or
higher education, and the proportions of cases and
controls receiving secondary school education and be-
yond were considerably lower than in the present
study [13].
One very possible explanation is that the more highly
educated people are, the more socially mobile they
become. They are therefore more likely to have moved
away from their families of origin where there is still a
strong cultural pressure to consume traditional dishes
containing unsafely prepared fish. In a sense, they have
broken free of family pressure to indulge in the strongly
ingrained cultural habit of eating raw fish. Of course,
such speculations need to be explored in future studies.
To the extent that this kind of explanation is correct, it
reinforces the importance of strategies designed to break
down the cultural attachment to the tradition of eating
raw fish. One such strategy is a ‘bottom-up’ approach of
working with communities in a participatory way to
loosen the cultural bonds with traditional dietary prac-
tices [56].
Strategies to minimise potential biases
Histological considerations
A histologically confirmed diagnosis should be required
for most cancer patient research participants [57], but
almost all studies in Thailand have failed to do this. In
the study by Chernrungroj [26] histological confirmation
of CCA was obtained for 28.0 % of the cases, in Honjo
et al. [27] only 7.0 % of the case diagnoses were histolog-
ically confirmed, and similarly the percentage was 7.4 %
in Poomphakwaen et al. [40]. Primary outcome and its
measurement without histological evidence can lead
to cases being incorrectly diagnosed with the result
that real exposure differences between cases and con-
trols are diluted, and the chances of demonstrating an
effect are reduced. .
Disease Misclassification
If the controls subsequently become CCA cases, this
would introduce a misclassification bias. To minimise
the potential for this kind of bias, thorough reviews of
medical records, operative notes and especially the sur-
gical pathology reports were obtained in order to con-
firm that the control group was unaffected by CCA. In
reality, such precautions may not always have been suc-
cessful because CCA is a non-acute disease.
Information bias
We minimised information bias by ‘blinding’ the trained
interviewer and pathologist so that they were unaware
whether subjects were in the case or control group. Fur-
thermore, the pathologist did not know the main factor
under investigation, and neither did the trained interviewer.
Confounding bias
The aim of matching was to control for confounder vari-
ables such as gender, age (within five years), and date of
admission (within three months). We took account of
other potential confounding variables by the use of mul-
tivariable conditional logistic regression.
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Strengths of the study
There were four important strengths of this study.
Firstly, the 210 cases were all incident events diagnosed
pathologically of having CCA by a pathologist in the
Department of Pathology at the Faculty of Medicine,
Khon Kaen University. Secondly, the current study is a
hospital-based matched case–control study which had
the largest number of pathologically proven CCA sub-
jects examined to date (210) and also the largest number
of controls. Thirdly, it is the first published study to
investigate the relationship between the number of
repeated PZQ treatments and CCA in human subjects.
Fourthly, the study demonstrated a dose response rela-
tionship between the number of repeated PZQ treat-
ments and CCA risk, and this can be considered as good
evidence of an underlying causal relationship [58].
Limitations of the study
Disease misclassification was possible because some con-
trol subjects may have been subsequently diagnosed with
CCA. CCA is usually a slow-growing tumor that spreads
locally via the lymphatic system, and it is often clinically
‘silent’ until a late stage.
Conclusions
The findings show that repeated PZQ treatments are
associated with an increased risk of CCA. Paradoxically,
this contradicts the common belief that repeated PZQ
treatments decrease the risk of CCA. This study also
showed a strong association between the number of re-
peated PZQ treatments and the consumption of raw fresh-
water fish, which suggests that repeated PZQ treatments
may be a surrogate marker of habit of eating raw fish.
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